These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 36094321)

  • 21. Different compounds against Angiotensin-Converting Enzyme 2 (ACE2) receptor potentially containing the infectivity of SARS-CoV-2: an in silico study.
    Shahbazi B; Mafakher L; Teimoori-Toolabi L
    J Mol Model; 2022 Mar; 28(4):82. PubMed ID: 35249180
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The binding of heparin to spike glycoprotein inhibits SARS-CoV-2 infection by three mechanisms.
    Paiardi G; Richter S; Oreste P; Urbinati C; Rusnati M; Wade RC
    J Biol Chem; 2022 Feb; 298(2):101507. PubMed ID: 34929169
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SARS-CoV-2 S protein:ACE2 interaction reveals novel allosteric targets.
    Raghuvamsi PV; Tulsian NK; Samsudin F; Qian X; Purushotorman K; Yue G; Kozma MM; Hwa WY; Lescar J; Bond PJ; MacAry PA; Anand GS
    Elife; 2021 Feb; 10():. PubMed ID: 33554856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conformational Flexibility and Local Frustration in the Functional States of the SARS-CoV-2 Spike B.1.1.7 and B.1.351 Variants: Mutation-Induced Allosteric Modulation Mechanism of Functional Dynamics and Protein Stability.
    Verkhivker G
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Computational analysis of protein stability and allosteric interaction networks in distinct conformational forms of the SARS-CoV-2 spike D614G mutant: reconciling functional mechanisms through allosteric model of spike regulation.
    Verkhivker GM; Agajanian S; Oztas D; Gupta G
    J Biomol Struct Dyn; 2022; 40(20):9724-9741. PubMed ID: 34060425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunotherapy approaches on innate immunity for SARS-Cov-2.
    Arslan BA; Timucin AC
    Acta Virol; 2020; 64(4):389-395. PubMed ID: 32985199
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glycoprotein molecular dynamics analysis: SARS-CoV-2 spike glycoprotein case study.
    Coutinho JVP; Macedo-da-Silva J; Mule SN; Kronenberger T; Rosa-Fernandes L; Wrenger C; Palmisano G
    Adv Protein Chem Struct Biol; 2022; 131():277-309. PubMed ID: 35871894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural and Computational Studies of the SARS-CoV-2 Spike Protein Binding Mechanisms with Nanobodies: From Structure and Dynamics to Avidity-Driven Nanobody Engineering.
    Verkhivker G
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328351
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of SARS-CoV-2 viral entry upon blocking N- and O-glycan elaboration.
    Yang Q; Hughes TA; Kelkar A; Yu X; Cheng K; Park S; Huang WC; Lovell JF; Neelamegham S
    Elife; 2020 Oct; 9():. PubMed ID: 33103998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interfacial Water in the SARS Spike Protein: Investigating the Interaction with Human ACE2 Receptor and In Vitro Uptake in A549 Cells.
    Singh AV; Kayal A; Malik A; Maharjan RS; Dietrich P; Thissen A; Siewert K; Curato C; Pande K; Prahlad D; Kulkarni N; Laux P; Luch A
    Langmuir; 2022 Jul; 38(26):7976-7988. PubMed ID: 35736838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of molecular interaction, physicochemical parameters and conserved pattern of SARS-CoV-2 Spike RBD and hACE2: in silico and molecular dynamics approach.
    Chakraborty C; Sharma AR; Mallick B; Bhattacharya M; Sharma G; Lee SS
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1708-1723. PubMed ID: 33629340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SARS-CoV-2 simulations go exascale to predict dramatic spike opening and cryptic pockets across the proteome.
    Zimmerman MI; Porter JR; Ward MD; Singh S; Vithani N; Meller A; Mallimadugula UL; Kuhn CE; Borowsky JH; Wiewiora RP; Hurley MFD; Harbison AM; Fogarty CA; Coffland JE; Fadda E; Voelz VA; Chodera JD; Bowman GR
    Nat Chem; 2021 Jul; 13(7):651-659. PubMed ID: 34031561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel Inhibitory Role of Fenofibric Acid by Targeting Cryptic Site on the RBD of SARS-CoV-2.
    Huang J; Chan KC; Zhou R
    Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced binding of the N501Y-mutated SARS-CoV-2 spike protein to the human ACE2 receptor: insights from molecular dynamics simulations.
    Luan B; Wang H; Huynh T
    FEBS Lett; 2021 May; 595(10):1454-1461. PubMed ID: 33728680
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Withanone from
    Balkrishna A; Pokhrel S; Singh H; Joshi M; Mulay VP; Haldar S; Varshney A
    Drug Des Devel Ther; 2021; 15():1111-1133. PubMed ID: 33737804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coevolution, Dynamics and Allostery Conspire in Shaping Cooperative Binding and Signal Transmission of the SARS-CoV-2 Spike Protein with Human Angiotensin-Converting Enzyme 2.
    Verkhivker G
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33158276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced Binding of SARS-CoV-2 Spike Protein to Receptor by Distal Polybasic Cleavage Sites.
    Qiao B; Olvera de la Cruz M
    ACS Nano; 2020 Aug; 14(8):10616-10623. PubMed ID: 32806067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrated Biophysical Modeling of the SARS-CoV-2 Spike Protein Binding and Allosteric Interactions with Antibodies.
    Verkhivker GM; Di Paola L
    J Phys Chem B; 2021 May; 125(18):4596-4619. PubMed ID: 33929853
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Common determinants of severe Covid-19 infection are explicable by SARS-CoV-2 secreted glycoprotein interaction with the CD33-related Siglecs, Siglec-3 and Siglec-5/14.
    Murch SH
    Med Hypotheses; 2020 Nov; 144():110168. PubMed ID: 33254494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction of Spike protein and lipid membrane of SARS-CoV-2 with Ursodeoxycholic acid, an in-silico analysis.
    Rodal Canales FJ; Pérez-Campos Mayoral L; Hernández-Huerta MT; Sánchez Navarro LM; Matias-Cervantes CA; Martínez Cruz M; Cruz Parada E; Zenteno E; Ramos-Martínez EG; Pérez-Campos Mayoral E; Romero Díaz C; Pérez-Campos E
    Sci Rep; 2021 Nov; 11(1):22288. PubMed ID: 34782703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.